Tools
Tools
Chitungo, Itai, Dzinamarira, Tafadzwa, Nyazika, Tinashe, Herrera, Helena, Musuka, Godfrey and Murewanhema, Grant (2022) 'Inappropriate Antibiotic Use in Zimbabwe in the COVID-19 Era: A Perfect Recipe for Antimicrobial Resistance'. Antibiotics, Vol 11, Issue 2, e244.
|
Text
antibiotics-11-00244.pdf - Published Version Available under License Creative Commons Attribution. Download (247kB) | Preview |
Abstract
The global COVID-19 pandemic has resulted in an upsurge in antimicrobial use. The increase in use is multifactorial, and is particularly related to the empirical treatment of SARS-CoV-2 and suspected coinfections with antimicrobials and the limited quality of diagnostics to differentiate viral and bacterial pneumonia. The lack of clear clinical guidelines across a wide range of settings, and the inadequacy of public health sectors in many countries, have contributed to this pattern. The increased use of antimicrobials has the potential to increase incidences of antimicrobial resistance, especially in low-resource countries such as Zimbabwe already grappling with multidrug-resistant micro-organism strains. By adopting the antimicrobial stewardship principles of the correct prescription and optimised use of antimicrobials, as well as diagnostic stewardship, revamping regulatory oversight of antimicrobial surveillance may help limit the occurrence of antimicrobial resistance during this pandemic.
| Item Type: | Article |
|---|---|
| Additional Information: | This article belongs to the Special Issue Antimicrobial Use and Stewardship during the COVID-19 Era |
| Subjects: | QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 268.5 Antiviral agents (General) QW Microbiology and Immunology > QW 45 Microbial drug resistance. General or not elsewhere classified. WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 506 COVID-19 |
| Faculty: Department: | Clinical Sciences & International Health > Malawi-Liverpool-Wellcome Programme (MLW) |
| Digital Object Identifer (DOI): | https://doi.org/10.3390/antibiotics11020244 |
| SWORD Depositor: | JISC Pubrouter |
| Depositing User: | JISC Pubrouter |
| Date Deposited: | 15 Jun 2022 14:57 |
| Last Modified: | 16 Jun 2023 08:37 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/19975 |
Statistics
Actions (login required)
 |
Edit Item |